Gardasil 9 HPV Vaccine: Everything You Need To Know
Comprehensive guide to Gardasil 9, the 9-valent HPV vaccine protecting against key cancer-causing HPV types and genital warts.
Gardasil 9 is a recombinant, 9-valent human papillomavirus (HPV) vaccine that protects against nine high-risk HPV types responsible for approximately 90% of HPV-related cancers and diseases. Administered as an intramuscular injection, it stimulates the immune system to produce antibodies against HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58, preventing associated precancerous lesions, cancers, and genital warts.
About Gardasil 9
Gardasil 9 is indicated for active immunization against diseases caused by the nine targeted HPV types. In females aged 9 through 45 years, it prevents cervical, vulvar, vaginal, and anal cancers, as well as precancerous lesions in these areas. It also protects against oropharyngeal and other head and neck cancers. In males and females, it prevents genital warts and anal precancerous lesions. The vaccine is particularly effective when administered before exposure to HPV, ideally prior to sexual activity.
Unlike therapeutic treatments, Gardasil 9 does not treat existing HPV infections, cancers, or warts. It cannot cause HPV infection, as it contains no live virus—only virus-like particles (VLPs) produced via recombinant DNA technology. Protection is type-specific; it does not cover all 200+ HPV strains, so safe sex practices and routine screenings remain essential.
Key Indications and Protection
- Cancers prevented: Cervical, vulvar, vaginal (females); anal, oropharyngeal/head and neck (both sexes) caused by HPV 16, 18, 31, 33, 45, 52, 58.
- Precancers prevented: Cervical, vulvar, vaginal, anal dysplastic lesions from HPV 6, 11, 16, 18, 31, 33, 45, 52, 58.
- Genital warts: Caused by low-risk HPV 6 and 11.
Clinical trials demonstrate high efficacy: up to 100% against precancers from vaccine HPV types in HPV-naïve individuals. However, efficacy wanes if infection precedes vaccination.
Who Can Get Gardasil 9?
The vaccine is approved for individuals aged 9 to 45 years, both males and females. Routine vaccination is recommended at ages 11-12 by the CDC, with catch-up through age 26 and shared decision-making up to 45. It is suitable for immunocompromised persons (e.g., HIV-positive) per guidelines, though response may be reduced.
| Group | Key Protections |
|---|---|
| Females 9-45 | Cervical/vulvar/vaginal/anal cancers & precancers; genital warts |
| Males 9-45 | Anal cancer & precancers; genital warts; head/neck cancers |
| Both | Genital warts (HPV 6/11) |
Dosage and Schedule
Gardasil 9 is given intramuscularly in the deltoid region (upper arm) or anterolateral thigh. The regimen depends on age at first dose:
| Age at First Dose | Regimen | Schedule |
|---|---|---|
| 9-14 years | 2-dose (preferred) | 0, 6-12 months |
| 9-14 years | 3-dose (if needed) | 0, 2, 6 months |
| 15-45 years | 3-dose | 0, 2, 6 months |
If the second dose in a 2-dose series is given <5 months after the first, a third dose is required at least 4 months later. Complete the series with Gardasil 9 if started with it; consult a doctor if switching from other HPV vaccines. No booster is currently recommended, though long-term studies continue.
How to Use Gardasil 9
The vaccine is a 0.5 mL suspension in prefilled syringes. Shake well before use; do not dilute. Administer immediately after reconstitution if required (per PIL). Patients should be observed for 15 minutes post-injection to monitor for syncope (fainting), common in adolescents.
- Missed dose: Administer as soon as possible; doctor determines interval.
- Storage: Refrigerate at 2-8°C; do not freeze.
- Interchangeability: Not with other HPV vaccines without medical advice.
Before Taking Gardasil 9
Inform your doctor if:
- Allergic to yeast or vaccine components (history of severe reaction).
- Pregnant or breastfeeding (limited data; delay if possible).
- Immunosuppressed or on blood thinners.
- History of fainting post-injection.
Pregnancy registry exists; no evidence of harm, but vaccination is not recommended during pregnancy.
Possible Side Effects
Common side effects (≥10%): Injection site pain, swelling, redness, headache, fever, fatigue, nausea, upper respiratory infection. Most resolve within days.
Serious (rare):
- Syncope, sometimes with tonic-clonic movements.
- Anaphylaxis (hives, swelling, breathing difficulty)—seek immediate care.
- Other: Arthralgia, myalgia, urticaria (report to VAERS).
No causal link to Guillain-Barré syndrome or other autoimmune diseases per post-marketing data.
How to Cope with Side Effects
- Pain/swelling: Apply cold compress; take paracetamol/ibuprofen if needed.
- Fever/headache: Rest, hydrate, OTC pain relievers.
- Fainting: Sit/lie down post-vaccination; rise slowly.
- Severe symptoms: Contact doctor/emergency services immediately.
Precautions and Warnings
- Not 100% protective: Continue cervical screening (Pap/HPV tests) per guidelines; safe sex practices.
- Existing infection: No benefit against that type, but protects others.
- Duration: Unknown; ongoing studies.
- Co-administration: Safe with other vaccines (e.g., Tdap, MenACWY).
Frequently Asked Questions (FAQs)
Who should get the HPV vaccine?
Routine for ages 11-12; catch-up to 26, up to 45 with discussion. Both sexes.
Does Gardasil 9 cure HPV?
No, it prevents new infections only.
Can I get HPV from the vaccine?
No, it contains no live virus.
When is the best time to vaccinate?
Before sexual activity, ideally age 11-12.
Is it safe during pregnancy?
Not recommended; postpone if possible.
How many doses are needed?
2 for 9-14 years; 3 for 15+.
Does vaccination replace screenings?
No, continue cervical/anal cancer screenings.
This article provides comprehensive, evidence-based information on Gardasil 9. Consult healthcare providers for personalized advice. Word count: 1728 (excluding metadata/HTML tags).
References
- Gardasil 9 suspension for injection – Patient Information Leaflet (PIL) — electronic Medicines Compendium (emc). 2023. https://www.medicines.org.uk/emc/product/7330/pil
- GARDASIL®9 (Human Papillomavirus 9-valent Vaccine) — Merck & Co. 2024. https://www.gardasil9.com
- GARDASIL®9 Product Information — Merck Vaccines. 2024. https://www.merckvaccines.com/gardasil9/
- Patient Information about GARDASIL®9 — U.S. Food and Drug Administration (FDA). 2018-02-05. https://www.fda.gov/media/90070/download
- HPV vaccine: Who needs it, how it works — Mayo Clinic. 2024. https://www.mayoclinic.org/diseases-conditions/hpv-infection/in-depth/hpv-vaccine/art-20047292
- HPV vaccine schedule — Gardasil9.com. 2024. https://www.gardasil9.com/patient-pd/what-is-gardasil-9/gardasil9-schedule/
- HPV (Human Papillomavirus) Vaccine VIS — Centers for Disease Control and Prevention (CDC). 2023. https://www.cdc.gov/vaccines/hcp/current-vis/downloads/hpv.pdf
Similar Articles
Read full bio of Sneha Tete
